Pamela Ann Connealy
CIK 1796310 · CFO & COO · last filed 2025-08-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.67M
Companies
4
Total Filings
26
Lifetime Open-Market Net
$229.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OBIO | Director | 48,711 | $4.10 | $199.7K | $0 | 8 | 2025-08-08 |
| PYXS | CFO & COO | 2,226,036 | $1.76 | $3.92M | $229.9K | 15 | 2025-04-02 |
| IMVT | Chief Financial Officer | 46,200 | $33.62 | $1.55M | $0 | 1 | 2021-03-23 |
| Immunovant, Inc. (IMVTW) Delisted | Chief Financial Officer | — | — | — | $0 | 2 | 2020-05-18 |
Recent Filings · Page 3 of 3
26 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-15 | PYXS | Grant (A) | +93,493 | $0 | EDGAR |
| 2022-04-04 | PYXS | Grant (A) | +247,524 | $0 | EDGAR |
| 2021-12-07 | PYXS | Grant (A) | — | $0 | EDGAR |
| 2021-03-23 | IMVT | Grant (A) | +46,200 | $0 | EDGAR |
| 2020-05-18 | Immunovant, Inc. (IMVTW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-20 | Immunovant, Inc. (IMVTW) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–26 of 26
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.